|
High $0.71 |
Low $0.67 |
Trades 144 |
Turnover $499,806 |
Volume 735,349 |
| 30 June 2023 at 4:10pm | ||||
|
Market Cap (14-Nov) $1,385,380,864 (515th) |
Close (30-Jun) $0.67 |
Volume (30-Jun) 735,349 |
Shortsold (9-Nov) 72,003,155 (11.95%) (12th) |
|
52w High $7.55 |
52w Low $1.40 |
P/E - |
EPS -0.38 |
4DMedical appoints experienced MedTech CFO
4DX released this announcement to the ASX on 24 June 2022, 8:29. The announcement is not marked as price sensitive, and is 2 page(s) in length and 206.64kb in size.
You can view all announcements from 4DX and see how they appear on a price chart on the announcements page.
At the date of this announcement, 4DX was 0.023% short sold according to ASIC data. It was ranked the 601st most shorted stock on the ASX. It is now ranked as the 12th most shorted stock on the ASX with 11.954% of total shares short sold as of the latest reported data (09 November 2026).
| Other Recent Announcements from 4DX | |
|---|---|
| Notification regarding unquoted securities - 4DX | 15 June 2023, 12:22 |
| Results of Meeting | 14 June 2023, 13:39 |
| EGM presentation and CEO address | 14 June 2023, 9:23 |
| 4DMedical appoints experienced MedTech CFO | 24 June 2022, 8:29 |
| Board Change - Executive Appointment | 23 May 2022, 16:02 |
| 4DMedical clinical trial results presented at ATS | 16 May 2022, 8:24 |
| Quarterly Activity Report and Appendix 4C for Q3 FY2022 | 29 April 2022, 9:31 |
If you were already registered, log in here.